Table 3. Potential epitopes of five selected outer membrane proteins from Shigella flexneri 2a that can elicit both B-cell and T-cell immune response.
Protein | B-cell epitope | Position | Length (aa) | B-cell epitope Vaxijen score | No. of promiscuous T-cell epitope | No. of bound HLA alleles | |
---|---|---|---|---|---|---|---|
HLA-I | HLA-II | ||||||
fepA | GVAQAQEPTDTPVSHDDTIVVTAA | 18–41 | 24 | 0.4103 | 15 | 28 | 10 |
MPGVNLTGNSTSGQRGNNRQIDIRGMGPEN | 74–103 | 30 | 1.8893 | 15 | 21 | 10 | |
LIDGKPVSSRNSVRQGWRGERDTRGDTSW | 107–135 | 29 | 1.2319 | 17 | 26 | 8 | |
YGNGAAGGVVNIITKKGSGE | 155–174 | 20 | 1.3339 | 10 | 17 | 45 | |
PEHKEEGATKRTNFSLTGPLGDEF | 186–209 | 24 | 0.9356 | 15 | 25 | 1 | |
GHQSARAGTYATTLPAGREGVINKDI | 230–255 | 26 | 0.6457 | 16 | 32 | 2 | |
GGWDNGVTTSNWVQYEHTRNSRIPEGLAGGTEGKFNEKATQ | 317–357 | 41 | 1.0477 | 28 | 38 | 25 | |
IVTPGLRFDHHSIVGNNWSPALNISQGLGDDF | 447–478 | 32 | 0.8752 | 18 | 30 | 15 | |
TNPNYILYSKGQGCYASAGG | 496–515 | 20 | 0.6557 | 10 | 17 | 18 | |
GQNAVGTDLYQWDNVPKAVVEG | 566–587 | 22 | 0.5469 | 10 | 29 | 13 | |
YMLKSENKTTGDRLSIIPEYT | 608–628 | 21 | 1.0732 | 11 | 20 | 1 | |
STLSWQAREDLSMQTTFTWYGKQQPKK | 631–657 | 27 | 0.5303 | 15 | 25 | 11 | |
QQPKKYNYKGQPAVGPETKEISPYSI | 653–678 | 26 | 0.8237 | 17 | 26 | 5 | |
DKRLWRAGNAQTTGDLAGANYIAGAGA | 702–728 | 27 | 0.9732 | 15 | 24 | 1 | |
ompC | KGETQVTDQLTGYGQWEYQIQGNSAENENNSWTRVAFAGLK | 62–102 | 41 | 0.7724 | 29 | 31 | 10 |
PEFGGDTYGSDNFMQQRGNGFAT | 129–151 | 23 | 0.9914 | 9 | 19 | 9 | |
FAVQYQGKNGSPEGEGMTNNG | 166–186 | 21 | 1.1887 | 9 | 13 | 28 | |
NRYDERYIGNGDRAETYTGGLKYDANNI | 228–255 | 28 | 0.7238 | 13 | 27 | 1 | |
nlpD_1 | GMLITPPPKMGTTSTAQQPQIQPVQQ | 50–75 | 26 | 0.7286 | 16 | 26 | 16 |
QPQIQPVQPVAQQPVQMENGRIVYNRQYGNIPKGSYSGSTY | 83–123 | 41 | 0.4008 | 27 | 34 | 29 | |
NVGQTLQVGNASGTPITGGNA | 158–178 | 21 | 1.1147 | 6 | 13 | 2 | |
QGVVIKPAQNSTVAVASQPTITYSESSGEQSAN | 187–219 | 33 | 0.8033 | 22 | 30 | 41 | |
WPTEGKVIETFGASEGGNKGIDIAGSKG | 262–289 | 28 | 1.0396 | 15 | 21 | 2 | |
tolC | DYTYSNGYRDANGINSNATSASLQLTQ | 69–95 | 27 | 1.1696 | 16 | 25 | 21 |
PELAALNVENFKTDKPQPVNALLK | 213–236 | 24 | 0.5435 | 15 | 37 | 11 | |
ASTGISDTSYSGSKTRGAAGTQYDDSNMGQN | 274–304 | 31 | 1.1866 | 12 | 18 | 2 | |
PIYQGGMVNSQVKQAQYNFVGAS | 313–335 | 23 | 0.5065 | 12 | 25 | 31 | |
DLLALNNALSKPVSTNPENVAPQT | 433–456 | 24 | 0.5650 | 14 | 27 | 16 | |
QTPEQNAIADGYAPDSPAPVVQQ | 455–477 | 23 | 0.4310 | 11 | 25 | 2 | |
nlpD_2 | GLLLAGCSGSKSSDTGTYSGSV | 28–49 | 22 | 1.2578 | 6 | 14 | 20 |
SPPYTIEVGQKLKLGGAKSSSSTRKSTAKSTTKT | 79–112 | 34 | 1.3560 | 23 | 34 | 30 |
In immunogenic sequences with more than one B cell epitope predicted, N-terminals of predicted B epitope sequences are underlined.
HLA, human leukocyte antigen.